Heres S - Search Results

1

Attitudes of psychiatrists toward antipsychotic depot medication.

Heres S, Hamann J, Kissling W, Leucht S. Heres S, et al. J Clin Psychiatry. 2006 Dec;67(12):1948-53. doi: 10.4088/jcp.v67n1216. J Clin Psychiatry. 2006. PMID: 17194274

2

[Influence of guideline recommendations, care structures and individual factors on the use of psychosocial therapies in severely mentally ill people].

Fritz S, Kösters M, Allgöwer A, Becker T, Kilian R, Gühne U, Riedel-Heller SG, Hasan A, Falkai P, Ajayi K, Baumgärtner J, Brieger P, Frasch K, Heres S, Jäger M, Küthmann A, Putzhammer A, Schneeweiß B, Schwarz M, Breilmann J. Fritz S, et al. Among authors: heres s. Psychiatr Prax. 2024 Apr;51(3):129-138. doi: 10.1055/a-2133-3527. Epub 2023 Oct 9. Psychiatr Prax. 2024. PMID: 37813363 Free article. German.

3

Language bias in neuroscience--is the Tower of Babel located in Germany?

Heres S, Wagenpfeil S, Hamann J, Kissling W, Leucht S. Heres S, et al. Eur Psychiatry. 2004 Jun;19(4):230-2. doi: 10.1016/j.eurpsy.2003.09.011. Eur Psychiatry. 2004. PMID: 15196606

4

Direct transition to long-acting risperidone--analysis of long-term efficacy.

Kissling W, Heres S, Lloyd K, Sacchetti E, Bouhours P, Medori R, Llorca PM. Kissling W, et al. Among authors: heres s. J Psychopharmacol. 2005 Sep;19(5 Suppl):15-21. doi: 10.1177/0269881105056514. J Psychopharmacol. 2005. PMID: 16144782 Clinical Trial.

5

Why olanzapine beats risperidone, risperidone beats quetiapine, and quetiapine beats olanzapine: an exploratory analysis of head-to-head comparison studies of second-generation antipsychotics.

Heres S, Davis J, Maino K, Jetzinger E, Kissling W, Leucht S. Heres S, et al. Am J Psychiatry. 2006 Feb;163(2):185-94. doi: 10.1176/appi.ajp.163.2.185. Am J Psychiatry. 2006. PMID: 16449469 Review.

6

Serotonin transporter polymorphisms and side effects in antidepressant therapy--a pilot study.

Popp J, Leucht S, Heres S, Steimer W. Popp J, et al. Among authors: heres s. Pharmacogenomics. 2006 Mar;7(2):159-66. doi: 10.2217/14622416.7.2.159. Pharmacogenomics. 2006. PMID: 16515395 Clinical Trial.

7

Epidemiology, clinical consequences, and psychosocial treatment of nonadherence in schizophrenia.

Leucht S, Heres S. Leucht S, et al. Among authors: heres s. J Clin Psychiatry. 2006;67 Suppl 5:3-8. J Clin Psychiatry. 2006. PMID: 16822090 Review.

8

Review: little evidence to support dose escalation of selective serotonin reuptake inhibitors in non-responders.

Heres S, Kissling W, Leucht S. Heres S, et al. Evid Based Ment Health. 2007 May;10(2):46. doi: 10.1136/ebmh.10.2.46. Evid Based Ment Health. 2007. PMID: 17459977 No abstract available.

9

Quetiapine is no less effective than risperidone for reducing symptoms of schizophrenia.

Heres S, Kissling W, Leucht S. Heres S, et al. Evid Based Ment Health. 2007 May;10(2):56. doi: 10.1136/ebmh.10.2.56. Evid Based Ment Health. 2007. PMID: 17459987 No abstract available.

10

Pretrial medication bias in randomized antipsychotic drug trials.

Leucht S, Heres S, Hamann J, Kissling W. Leucht S, et al. Among authors: heres s. Am J Psychiatry. 2007 Aug;164(8):1266; author reply 1266-7. doi: 10.1176/appi.ajp.2007.07030404. Am J Psychiatry. 2007. PMID: 17671291 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

90 results

Search Page

Filters